$AFYA News

Afya Got Some Regulatory Respite But The Education Quality Risk Remains

Afya Confirms Discussions With Yduqs Regarding Possible Business Combination

Reported earlier, Afya Raises FY2026 Sales Guidance from $731.710M-$759.496M to $750.168M-$778.656M vs $781.560M Est

Afya Limited 2026 Q2 - Results - Earnings Call Presentation

Afya Limited (AFYA) Q2 2026 Earnings Call Transcript

JP Morgan Maintains Neutral on Afya, Lowers Price Target to $21

Afya Ltd (NASDAQ:AFYA) Passes Stringent 'Caviar Cruise' Quality Screen with Exceptional Growth and Value Metrics

AFYA vs. APEI: Which Stock Is the Better Value Option?

Afya Limited Releases 2025 Integrated Report

Afya's Recent National Exam Scores Are Worrying

Afya Limited (the "Company") Notice of Annual General Meeting of the Company

Afya (NasdaqGS:AFYA) Valuation Check As Shares Trade Near Recent Levels

Should Value Investors Buy Afya (AFYA) Stock?

Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know

AFYA LTD-CLASS A (NASDAQ:AFYA): A Caviar Cruise Quality Screen Standout

Are Investors Undervaluing Afya (AFYA) Right Now?

Afya Ltd (AFYA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Competitive ...

Reported earlier, Afya Affirms FY2026 Sales Guidance of $731.710M-$759.496M vs $760.310M Est

Reported Earlier, Afya Q1 EPS $0.55 Beats $0.54 Estimate, Sales $192.330M Beat $191.870M Estimate

Afya Limited Announces First-Quarter 2026 Financial Results